Cost-Effectiveness Analysis of Using Loss of Heterozygosity to Manage Premalignant Oral Dysplasia in British Columbia, Canada

DOI: 10.1634/theoncologist.2015-0433

Keywords: Cost-effectiveness, Decision modeling, Mouth neoplasms, Precancerous conditions, Genetic testing

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text